0001213900-24-018671.txt : 20240229
0001213900-24-018671.hdr.sgml : 20240229
20240229195308
ACCESSION NUMBER: 0001213900-24-018671
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reich Kristian
CENTRAL INDEX KEY: 0001920553
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39630
FILM NUMBER: 24706357
MAIL ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MoonLake Immunotherapeutics
CENTRAL INDEX KEY: 0001821586
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
BUSINESS PHONE: 41 41 510 8022
MAIL ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
FORMER COMPANY:
FORMER CONFORMED NAME: Helix Acquisition Corp
DATE OF NAME CHANGE: 20200818
4
1
ownership.xml
X0508
4
2024-02-27
0
0001821586
MoonLake Immunotherapeutics
MLTX
0001920553
Reich Kristian
C/O MOONLAKE IMMUNOTHERAPEUTICS
DORFSTRASSE 29
ZUG
V8
6300
SWITZERLAND
0
1
0
0
Chief Scientific Officer
1
Class A ordinary shares, par value $0.0001 per share
2024-02-27
4
S
0
29491
55.00
D
2957483
I
See footnote.
Class A ordinary shares, par value $0.0001 per share
2024-02-27
4
S
0
29431
55.00
D
70071
D
Class A ordinary shares, par value $0.0001 per share
2024-02-28
4
S
0
31910
55.00
D
2925573
I
See footnote.
Class A ordinary shares, par value $0.0001 per share
2024-02-28
4
S
0
28090
55.00
D
41981
D
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 16, 2023.
Represents the ordinary shares of the Issuer owned by JeruCON Beratungsgesellschaft mbH. Dr. Reich directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the ordinary shares owned by JeruCON Beratungsgesellschaft mbH.
/s/ Matthias Bodenstedt, Attorney-in-fact for Kristian Reich
2024-02-29